BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 7579714)

  • 1. Assembly and function of integrin receptors is dependent on opposing alpha and beta cytoplasmic domains.
    Briesewitz R; Kern A; Marcantonio EE
    Mol Biol Cell; 1995 Aug; 6(8):997-1010. PubMed ID: 7579714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid motifs required for isolated beta cytoplasmic domains to regulate 'in trans' beta1 integrin conformation and function in cell attachment.
    Mastrangelo AM; Homan SM; Humphries MJ; LaFlamme SE
    J Cell Sci; 1999 Jan; 112 ( Pt 2)():217-29. PubMed ID: 9858475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-dependent and -independent integrin focal contact localization: the role of the alpha chain cytoplasmic domain.
    Briesewitz R; Kern A; Marcantonio EE
    Mol Biol Cell; 1993 Jun; 4(6):593-604. PubMed ID: 7690620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping in vivo associations of cytoplasmic proteins with integrin beta 1 cytoplasmic domain mutants.
    Lewis JM; Schwartz MA
    Mol Biol Cell; 1995 Feb; 6(2):151-60. PubMed ID: 7540435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The membrane-cytoplasm interface of integrin alpha subunits is critical for receptor latency.
    Briesewitz R; Kern A; Smilenov LB; David FS; Marcantonio EE
    Mol Biol Cell; 1996 Oct; 7(10):1499-509. PubMed ID: 8898357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha1 Integrin cytoplasmic domain is involved in focal adhesion formation via association with intracellular proteins.
    Löster K; Vossmeyer D; Hofmann W; Reutter W; Danker K
    Biochem J; 2001 May; 356(Pt 1):233-40. PubMed ID: 11336656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic tails of beta 1, beta 2, and beta 7 integrins differentially regulate LFA-1 function in K562 cells.
    Lub M; van Vliet SJ; Oomen SP; Pieters RA; Robinson M; Figdor CG; van Kooyk Y
    Mol Biol Cell; 1997 Apr; 8(4):719-28. PubMed ID: 9247650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta1-integrin cytoplasmic subdomains involved in dominant negative function.
    Retta SF; Balzac F; Ferraris P; Belkin AM; Fässler R; Humphries MJ; De Leo G; Silengo L; Tarone G
    Mol Biol Cell; 1998 Apr; 9(4):715-31. PubMed ID: 9529373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the alpha1 and alpha2 integrin cytoplasmic domains in cell morphology, motility and responsiveness to stimulation by the protein kinase C pathway.
    Wang H; Gai Q; Yang X; Li Z; Linders B; Santoro SA; Zutter MM
    Cell Adhes Commun; 2000 Jan; 7(4):281-97. PubMed ID: 10714390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin alpha 2 cytoplasmic domain deletion effects: loss of adhesive activity parallels ligand-independent recruitment into focal adhesions.
    Kawaguchi S; Bergelson JM; Finberg RW; Hemler ME
    Mol Biol Cell; 1994 Sep; 5(9):977-88. PubMed ID: 7841525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin functions in receptor localization, cell spreading and migration, and matrix assembly.
    LaFlamme SE; Thomas LA; Yamada SS; Yamada KM
    J Cell Biol; 1994 Sep; 126(5):1287-98. PubMed ID: 8063864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an interaction between the m-band protein skelemin and beta-integrin subunits. Colocalization of a skelemin-like protein with beta1- and beta3-integrins in non-muscle cells.
    Reddy KB; Gascard P; Price MG; Negrescu EV; Fox JE
    J Biol Chem; 1998 Dec; 273(52):35039-47. PubMed ID: 9857037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.
    Calderwood DA; Fujioka Y; de Pereda JM; García-Alvarez B; Nakamoto T; Margolis B; McGlade CJ; Liddington RC; Ginsberg MH
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2272-7. PubMed ID: 12606711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mutations in the cytoplasmic domain of integrin beta(1) to talin binding and cell spreading.
    Kääpä A; Peter K; Ylänne J
    Exp Cell Res; 1999 Aug; 250(2):524-34. PubMed ID: 10413605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 1 integrin-dependent and -independent polymerization of fibronectin.
    Wennerberg K; Lohikangas L; Gullberg D; Pfaff M; Johansson S; Fässler R
    J Cell Biol; 1996 Jan; 132(1-2):227-38. PubMed ID: 8567726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains.
    Tulla M; Pentikäinen OT; Viitasalo T; Käpylä J; Impola U; Nykvist P; Nissinen L; Johnson MS; Heino J
    J Biol Chem; 2001 Dec; 276(51):48206-12. PubMed ID: 11572855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of the cytoplasmic domain of the integrin alpha 5 subunit.
    Bauer JS; Varner J; Schreiner C; Kornberg L; Nicholas R; Juliano RL
    J Cell Biol; 1993 Jul; 122(1):209-21. PubMed ID: 7686163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a talin-binding site in the integrin beta(3) subunit distinct from the NPLY regulatory motif of post-ligand binding functions. The talin n-terminal head domain interacts with the membrane-proximal region of the beta(3) cytoplasmic tail.
    Patil S; Jedsadayanmata A; Wencel-Drake JD; Wang W; Knezevic I; Lam SC
    J Biol Chem; 1999 Oct; 274(40):28575-83. PubMed ID: 10497223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin beta 1 cytoplasmic domain dominant negative effects revealed by lysophosphatidic acid treatment.
    Smilenov L; Briesewitz R; Marcantonio EE
    Mol Biol Cell; 1994 Nov; 5(11):1215-23. PubMed ID: 7532472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the avidity of integrin alpha 4 beta 7 by the beta 7 cytoplasmic domain.
    Crowe DT; Chiu H; Fong S; Weissman IL
    J Biol Chem; 1994 May; 269(20):14411-8. PubMed ID: 8182047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.